Evidence map›Paper›PMID 31261773›Full record

ArticleInternational journal of molecular sciences2019

Importance of the Choice of a Recombinant System to Produce Large Amounts of Functional Membrane Protein hERG.

Lucie Vasseur, Thierry Cens, Renaud Wagner, Nathalie Saint, Valérie Kugler, Alain Chavanieu, Christine Ouvry, Clémence Dupré, Gilles Ferry, Jean A Boutin

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. ArrhythmoGenoPharmacoTherapy.Frontiers in pharmacology · 2020
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Lucie VasseurInstitut des Biomolécules Max Mousseron, Université de Montpellier, 34090 Montpellier, France.
Thierry CensInstitut des Biomolécules Max Mousseron, Université de Montpellier, 34090 Montpellier, France.
Renaud WagnerPlateforme IMPReSs, CNRS UMR7242, Biotechnologie et Signalisation Cellulaire, Ecole Supérieure de Biotechnologie de Strasbourg, 67400 Illkirch, France.
Nathalie SaintPHYMEDEXP, Université de Montpellier, CNRS, INSERM, 34090 Montpellier, France.
Valérie KuglerPlateforme IMPReSs, CNRS UMR7242, Biotechnologie et Signalisation Cellulaire, Ecole Supérieure de Biotechnologie de Strasbourg, 67400 Illkirch, France.
Alain ChavanieuInstitut des Biomolécules Max Mousseron, Université de Montpellier, 34090 Montpellier, France.
Christine OuvryPEX Biotechnologie, Chimie & Biologie, Institut de Recherches SERVIER, 78290 Croissy-sur-Seine, France.
Clémence DupréPEX Biotechnologie, Chimie & Biologie, Institut de Recherches SERVIER, 78290 Croissy-sur-Seine, France.
Gilles FerryPEX Biotechnologie, Chimie & Biologie, Institut de Recherches SERVIER, 78290 Croissy-sur-Seine, France.
Jean A BoutinInstitut de Recherches Internationales SERVIER, Suresnes, France. jean.boutin@servier.com.
Centre National de la Recherche Scientifique · FRPlateforme Technologique d'Innovation Biomédicale · FRUniversité de Montpellier · FRServier (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human ether-a-gogo related gene (hERG) product is the membrane potassium channel Kv11.1, which is involved in the electrical activity of the heart. As such, it is a key player in the toxicity of many drug candidates. Therefore, having this protein at hand during earlier stages of drug discovery is important for preventing later toxicity. Furthermore, having a fair quantity of functional channels may help in the development of the necessary techniques for gaining insight in this channel structure. Thus, we performed a comparative study of methods for over-expressing a mutated but functional, hERG in different orthologous hosts, such as yeast, bacteria, insect and human cell lines. We also engineered the protein to test various constructs of a functional channel. We obtained a significant amount of a functional mutant channel from HEK cells that we thoroughly characterized. The present work paves the way for the expression of large amounts of this protein, with which protein crystallization or cryo-electronic microscopy will be attempted. This will be a way to gain information on the structure of the hERG active site and its modelization to obtain data on the pauses of various reference compounds from the pharmacopeia, as well as to gain information about the thermodynamics of the hERG/ligand relationship.

Indexed as

AnimalsChemical FractionationCrystallography, X-RayERG1 Potassium ChannelHEK293 CellsHumansPichiaProtein EngineeringRecombinant ProteinsSf9 CellsSpodopteraXenopusERG1 Potassium ChannelKCNH2 protein, humanRecombinant Proteinsbaculovirus expression systemE. coliexpressionfunctional characterizationHEK cellshERGKv11.1P. pastorispurification

Identifiers

PMID31261773
PMCPMC6651182
OpenAlexW2955738885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.